Sixteen of these 26 patients presented one or more high risk factors including age, high WBC count, PPR, fusions MLL-AF9 or BCR-ABL1, extramedullary disease and T cell immunophenotype. This evidence concerns the gene KMT2A and glycogen storage disease VI.